Authors
Loading...
Global proteomics reveals NAMPT as a therapeutic target in high-risk MDS, enhancing azacitidine's efficacy.
Moreira et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: